Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 795 M857 M998 M969 M1.11 B1.05 B 4.12 B Research & development 538 M568 M610 M587 M589 M638 M 2.42 B Operating income 430 M38 M612 M1.63 B269 M86 M 2.59 B Non-Operating Income, Total 192 M135 M167 M167 M124 M195 M 653 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 183 M173 M190 M180 M162 M155 M 687 M Unusual income/expense 9 M-38 M-23 M-13 M-38 M40 M -34 M Pretax income 622 M173 M779 M1.79 B393 M281 M 3.25 B Equity in earnings —————— — Taxes 161 M19 M137 M418 M52 M121 M 728 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 461 M154 M642 M1.37 B341 M160 M 2.52 B Discontinued operations —————— — Net income 461 M154 M642 M1.37 B341 M160 M 2.52 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 462 M155 M643 M1.38 B341 M160 M 2.52 B Basic earnings per share (Basic EPS) 0.740.251.042.250.560.27 4.12 Diluted earnings per share (Diluted EPS) 0.710.241.032.210.550.26 4.05 Average basic shares outstanding 632 M621 M615 M611 M613 M598 M — Diluted shares outstanding 645 M632 M626 M621 M623 M608 M — EBITDA 452 M63 M———— — EBIT 430 M38 M612 M1.63 B269 M86 M 2.59 B Cost of revenue 427 M506 M544 M549 M487 M581 M 2.16 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 22 M25 M———— —